SQUAWK/NEWS
Account
Theme
Account
Menu
Live News MNA FLASH L impact

BioSyent Releases Financial Results for Q3 and YTD 2026

MISSISSAUGA, Ontario, Nov. 17, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its consolidated financial results for the three months (Q3), nine months (YTD), and trailing twelve months (TTM) ended September 30, 2026. Key highlights include:“Our recently acquire…

RX

Related stories